Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Malaria Journal|March 3, 2025
An observational pilot study of an active surveillance tool to enhance pharmacovigilance in BrazilDhelio Batista Pereira, Marcus Vinícius Guimarães Lacerda, Pavandeep Bilkhu, et al.Malaria Journal|May 13, 2024
Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malariaRaman Sharma, Hema Sharma, Siôn Jones, et al.British Journal of Clinical Pharmacology|November 24, 2017
A human microdose study of the antimalarial drug GSK3191607 in healthy volunteersMalek Okour, Geo Derimanov, Rodger Barnett, et al.Journal of Clinical Pharmacology|March 7, 2026
Combined Oral Contraceptive Drug-Drug Interaction Study With Ganfeborole, a New Anti-Tuberculosis AgentLaura Iavarone, Silvia M Lavezzi, Antonio J Carcas, et al.The Lancet. Child & Adolescent Health|December 6, 2021
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trialIván D Vélez, Tran T Hien, Justin A Green, et al.The Lancet. Neurology|September 12, 2014
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 studyThomas Voit, Haluk Topaloglu, Volker Straub, et al.Blood|May 1, 2016
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiencyMaria Pia Cicalese, Francesca Ferrua, Laura Castagnaro, et al.The Lancet. Infectious Diseases|May 26, 2023
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety studyInge Sutanto, Amin Soebandrio, Lenny L Ekawati, et al.Pageof 2